TY  - CHAP
M1  - Book, Section
TI  - Conflict of Interest Disclosure and Mitigation
A1  - DiPiro, Joseph T.
A1  - Yee, Gary C.
A1  - Posey, L. Michael
A1  - Haines, Stuart T.
A1  - Nolin, Thomas D.
A1  - Ellingrod, Vicki
Y1  - 2020
N1  - 
T2  - Pharmacotherapy: A Pathophysiologic Approach, 11e
AB  - Contributors  to  Pharmacotherapy:  A  Pathophysiologic  Approach  must  disclose  relevant  financial  and  other  interests  with  entities  that  produce,  market,  sell,  or  distribute  medications,  health  products,  or  services  related  to  the  medication  use  process.  All  contributors  will  complete,  sign,  and  submit  a  conflict  of  interest  (COI)  disclosure  statement  to  the  Editors.  Starting  with  the  11th  edition,  the  COI  disclosure  must  be  submitted  after  an  invitation  has  been  extended  and  before  a  contributor  agreement  is  signed.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=1198989586
ER  -